USPTO issues NOA to Watson Pharma key progesterone preterm birth patent
The patent application was among the assets Columbia Laboratories sold to Watson in July 2010. The patent will cover Crinone and Prochieve (progesterone gels) and any products in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.